Various c-Met inhibitors have recently been developed and experimentally evaluated as potential drugs for treatment of human cancers (Maulik et al, 2002; Trusolino and Comoglio, 2002; Ma et al, 2003; Christensen et al, 2005). The gene discussed is MET; the disease is cancer.